Backed by an initial investment of $11 million from the Bill & Melinda Gates Foundation, the initiative leverages Field’s proprietary technology, distribution network, and financing services to deliver innovative therapies to communities in need.

Field’s service currently supports over 40,000 healthcare providers in Kenya and Nigeria, providing them with the tools and resources necessary to improve patient outcomes.

The company’s CEO and Founder, Michael Moreland, highlighted the importance of utilizing digital technology to enhance access to quality care, emphasizing that the partnership with the Bill & Melinda Gates Foundation will accelerate progress in maternal and child survival.

According to data, women in sub-Saharan Africa face a disproportionately high risk of maternal mortality, with a rate that is significantly higher than in developed regions.

To address this urgent issue, Field’s service will provide expectant mothers with access to emerging therapies such as heat-stable carbetocin and calibrated drapes, which can help prevent and treat postpartum hemorrhage.

Despite advancements in healthcare delivery, economic challenges can hinder progress in improving maternal and child health.

Field is committed to overcoming these obstacles by providing coordinated systems and processes that support the implementation of innovative interventions.

Founded in 2015, Field has established itself as a leading pharmaceutical supply chain provider in Nigeria and Kenya.

The company’s distribution service, Shelf Life, reaches over 2,500 pharmacies and hospitals across the two countries, ensuring access to essential medicines and healthcare products.

Additionally, Field offers trade financing solutions to address working capital constraints and facilitate investments in new medical interventions.